1093975-68-8

Basic information

• Product Name: 8-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)quinoline
• CAS NO: 1093975-68-8
• Molecular Weight: 396.451
• Mol File: 1093975-68-8.mol

Chemical Properties

• CAS DataBase Reference: 8-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)quinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 8-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)quinoline(1093975-68-8)
• EPA Substance Registry System: 8-({4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl}methyl)quinoline(1093975-68-8)

Safety Data

• Hazardous Substances Data: 1093975-68-8(Hazardous Substances Data)

Upstream product

• 128495-46-5 4-fluoro-3-methoxybenzaldehyde 
• 131052-51-2 8-(azidomethyl)quinoline 
• 1093980-57-4 1-(4-ethynyl-2-methoxyphenyl-4-methyl-1H-imidazole) 
• 870837-18-6 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde 

Relevant articles and documents

Triazoles as γ-secretase modulators

Synthesis, SAR, and evaluation of aryl triazoles as novel gamma secretase modulators (GSMs) are presented in this communication. Starting from the literature and in-house leads, we evaluated a range of five-membered heterocycles as replacements for olefin

TRIAZOLE DERIVATIVES FOR TREATING ALZHEIMER'S DISEASE AND RELATED CONDITIONS

Compounds of formula I: Selectively attenuate production of Aβ(1-42) and hence find use in treatment or prevention of diseases associated with deposition of Aβ in the brain, in particular Alzheimer's disease.